๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Criterion to re-open hydroprocessing catalyst plant

Publisher
Elsevier Science
Year
2005
Weight
36 KB
Volume
2005
Category
Article
ISSN
1351-4180

No coin nor oath required. For personal study only.

โœฆ Synopsis

VioQuest Pharmaceuticals expands commercial catalyst portfolio

VioQuest Pharmaceuticals Inc is pleased to announce that subsidiary Chiral Quest has introduced its proprietary chiral catalyst DuanPhos for commercial-scale shipping on a kilogram scale. VioQuest, in addition to acquiring innovative oncologic, metabolic, and anti-inflammatory therapeutic compounds for unmet medical needs, offers a growing family of latest generation technology in the manufacture of optically pure therapeutics for the pharmaceutical industry. VioQuest Pharmaceuticals Inc is a drug development company focused on acquiring and bringing to market therapies for oncology, metabolic, and inflammatory diseases and disorders that are current unmet medical needs.

๐Ÿ“œ SIMILAR VOLUMES

Criterion Catalysts & Technologies opens
Criterion Catalysts & Technologies opens flagship plant in Port Allen
๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› Elsevier Science โš– 59 KB

## UOP and Total Petrochemicals successfully demonstrate technology to produce plastics from non-oil feedstocks UOP LLC, a Honeywell International Inc company, announced on 6 Jul 2010 that Total Petrochemicals has demonstrated UOP technology that will enable the use of feedstocks other than petrole